Alexandra Zhang, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 566 White Pond Dr, Suite E, Akron, OH 44320 Phone: 330-535-7100 |
Dr. Nicholas Viet Nguyen, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-4970 Fax: 330-543-4971 |
Christine M Adamick, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 190 N Union St, Ste 203, Akron, OH 44304 Phone: 330-923-3502 Fax: 330-928-9761 |
Dr. Eliot Nathan Mostow, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 566 White Pond Dr, Ste E, Akron, OH 44320 Phone: 330-535-7100 Fax: 330-535-2600 |
Dr. Julie Ar Mark, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: One Park West Blvd., Suite 370, Akron, OH 44320 Phone: 330-835-9158 Fax: 330-835-4984 |
Nicole Naples, NP-C Dermatology - Pediatric Dermatology Medicare: Medicare Enrolled Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-542-8224 |
Raj Patel, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 566 White Pond Dr Ste E, Akron, OH 44320 Phone: 330-535-7100 |
Linda L Alston, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3085 W Market St, #102, Akron, OH 44333 Phone: 330-836-0201 Fax: 330-836-9406 |
Dr. Daniel C Grove, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 215 W Bowery St, Akron, OH 44308 Phone: 330-543-3376 |
News Archive
Fake medicines increasingly put patients and the general public at risk across the world. In response to this challenge, ten partners who represent healthcare professionals, disease-specific organizations, product-development partnerships, foundations, international financing institutions, as well as the research-based pharmaceutical industry have joined forces to raise awareness about the dangers of fake medicines.
Researchers at the University of California, San Diego School of Medicine have compiled the first-ever review of the neurobiology of wisdom – once the sole province of religion and philosophy.
Canadian Red Cross Secretary General and CEO Conrad Sauvé is pleased to represent the International Federation of Red Cross Red Crescent Societies (IFRC) at the Ministerial Preparatory Conference on Haiti in Montreal on Jan. 25, 2010.
Amgen today announced that the Japanese Ministry of Health, Labour and Welfare has approved the cholesterol-lowering medication Repatha (evolocumab) Injection, the first proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor to be approved in Japan.
› Verified 1 days ago